Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.

Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M; Costa Rica HPV Vaccine Trial (CVT) Group.

Sex Transm Dis. 2011 Oct;38(10):976-82. doi: 10.1097/OLQ.0b013e31822545c0.

2.

Determinants of seropositivity among HPV-16/18 DNA positive young women.

Porras C, Bennett C, Safaeian M, Coseo S, Rodríguez AC, González P, Hutchinson M, Jiménez S, Sherman ME, Wacholder S, Solomon D, van Doorn LJ, Bougelet C, Quint W, Schiffman M, Herrero R, Hildesheim A; Costa Rica HPV Vaccine Trial (CVT) Group.

BMC Infect Dis. 2010 Aug 11;10:238. doi: 10.1186/1471-2334-10-238.

3.

Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.

Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M; Costa Rica HPV Vaccine Trial (CVT) Group.

Sex Transm Dis. 2010 Nov;37(11):706-14. doi: 10.1097/OLQ.0b013e3181e1a2c5.

PMID:
20661178

Supplemental Content

Write to the Help Desk